Len Zehr
Len Zehr
Send Message
Len Zehr
Stop FollowingLen Zehr
View as an RSS Feed
View Len Zehr's Articles BY TICKER:
- Galena Targets Cancer Pain Market
- Oramed Readies Oral Insulin Study In U.S.
- BioLineRx Pipeline Returns To The Winner's Circle
- BioDelivery On Track For Mid-Year NDA Filing
- OncoGenex's Second Cancer Drug Gaining Investor Attention
- Sucampo Should See Revenue From 3 Continents By Year-End
- All Eyes On Ohr Pharma Wet AMD Study
- Prima BioMed To Get Key Data In Second Half
- Rockwell Medical Readying 2 Drugs For Dialysis
- Novadaq Highlights Game Changer For The OR
-
Transition Therapeutics Awaiting Competing AD Trial Results
- IntelGenx Striving To Create A Second Biovail
- Pluristem Pioneering Intramuscular Placenta-Based Cell Therapies
- AMRI Turnaround At Inflection Point
- NovaBay Ocular Trial Taps Broad Activity Of Its Anti-Infective
- Avita's Breakthrough Treatment For Burns, Wounds And Scars
- NovaBay's Aganocide Outperformed Antibiotics In Study
- MediciNova To Release Asthma And COPD Trial Results In Q2
- Psivida Licensee Set For European Launch By Year's End
- How OncoSec Opens Up Skin Cancer Cells To Drugs
- NovaBay Anti-Infective Programs Mitigate Risk
- N.Y. Approval Of ColonSentry Opens Door For GeneNews And Enzo
- A Talk With Roth Capital Medical Technology Analyst Matt Dolan
- Novadaq Partnering Strategy Hits Marketing Milestone
- Cellceutix Eyeing A $5B Annual Market With Potential Caner Research Breakthrough
- D. Medical Pumps Up Diabetic Infusion Sets
- Marshall Edwards Taking Big Pharma Clinical Path
- BioSante: Study Generates Confidence For Future Treatment
- Neptune Technologies: It's All About the Krill Oil
- Psivida on the Cusp of Big Breakthrough
- Somaxon Is a Sleeper in the Insomnia Market
- Synta Readying 2 Key Lung Cancer Trials
